Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-03

Clinical Trial Update: Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2 [NA]

View source ↗

Summary

A completed clinical trial comparing the Frequency-altering AKE-1 Capsule with the PillCam SB2 for intestinal diseases and GI hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AKE-1 Capsule
  • PillCam SB2

Snippet

Sponsor: Changhai Hospital | Conditions: Intestinal Diseases, Gastrointestinal Hemorrhage | NA | Status: COMPLETED